Cholastin

Cholastin

atorvastatin

Manufacturer:

Gracia Pharmindo
Concise Prescribing Info
Contents
Atorvastatin Ca
Indications/Uses
Adjunct to diet for the reduction of elevated total cholesterol (total-C), LDL-C, apo-B & triglycerides in patients w/ primary hypercholesterolemia, combined (mixed) hyperlipidemia & heterozygous & homozygous familial hypercholesterolemia when diet response & other nonpharmacological measures are inadequate. Hypertensive patient (≥40 yr) & dyslipidemia w/ at least 3 risk factor for future CV events eg, LVH, ECG abnormalities, NIDDM, peripheral vascular disease, post-history of cerebrovascular events eg, TIA ≥3 mth previously, microalbuminaria/proteinuria, smoking (regular smoker w/in the last yr of 20 cigarettes or cigars/wk), TC/HDL-C ratio 6 & history of CAD event in 1st degree relative before age 55 (males) or 60 (women). Reduced risk of fatal CHD & non-fatal MI, stroke & revascularization procedures & angina pectoris. Adjunct to diet to reduce total-C, LDL-C & Apo B levels in boys & postmenarchal girls 10-17 yr w/ heterozygous familial hypercholesterolemia if after adequate diet therapy LDL-C remains ≥190 mg/dL or ≥160 mg/dL & there is +ve family history of premature CV disease or ≥2 other CV disease risk factors.
Dosage/Direction for Use
Usual dose: 10 mg once daily. Dose range: 10-80 mg daily. Primary hypercholesterolemia & combined (mixed) hyperlipidemia 10 mg once daily. Homozygous familial hypercholesterolemia 80 mg. Heterozygous hypercholesterolemia in childn 10-17 yr Initially 10 mg daily. Max dose: 20 mg daily. Dose adjustment should be made at intervals of ≥4 wk.
Administration
May be taken with or without food.
Contraindications
Hypersensitivity. Active liver disease or unexplained persistent elevations of serum transaminases >3 x ULN. Pregnancy & lactation.
Special Precautions
Perform LFT prior to treatment. Patients w/ myalgia; suffering from unexplained muscle pain, tenderness or weakness especially those accompanied w/ malaise or fever. Women of childbearing potential.
Adverse Reactions
Asthenia; insomnia; headache; nausea, diarrhea, abdominal pain, dyspepsia, constipation, flatulence; myalgia, arthralgia.
Drug Interactions
Increased risk of myopathy w/ concurrent use of cyclosporin, fibric acid derivatives, niacin or CYP450 3A4 inhibitors eg, erythromycin, azole antifungals. Increased plasma conc w/ CYP450 3A4 cytochrome inhibitors. Increased bioavailability w/ OATP1B1 inhibitors eg, cyclosporine. Concomitant use w/ erythromycin, clarithromycin, PIs, diltiazem HCl, itraconazole; CYP450 3A inducers eg, efavirenz, rifampicin; Mg- & Al-hydroxide-containing oral antacids; antipyrine, colestipol, digoxin, azithromycin, amlodipine, fusidic acid, ketoconazole, spironolactone, cimetidine.
MIMS Class
Dyslipidaemic Agents
ATC Classification
C10AA05 - atorvastatin ; Belongs to the class of HMG CoA reductase inhibitors. Used in the treatment of hyperlipidemia.
Presentation/Packing
Form
Cholastin FC caplet 20 mg
Packing/Price
3 × 10's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in